Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Fatty's Donut Shop -- Ignore unavailable to you. Want to Upgrade?

To: Michael E. Baldino who wrote (697)	4/17/1999 2:26:00 PM
From: Sprintcar	Read Replies (1) \| Respond to of 5041

WASP...Stock just made a run where does it go from here? Up or down to form a new base....Little late for now isn't it. Sprintcar

To: Michael E. Baldino who wrote (697)	4/17/1999 2:37:00 PM
From: Matt Brown	Read Replies (1) \| Respond to of 5041

FM's Notes on WASP These are just my views. I hold no position as of yet in this stock. I am simply researching it and presenting my thoughts. With the success of this therapy, entry into the retail market has been solicited by an independent distributor representing eighteen hundred pharmacies. In addition, two major retail chains representing over 30% of the over-the-counter market are accessible through relationships presently representing Wasatch Pharmaceutical. It appears that the market and the distributors are already there and in place. All they need to do is release the goods and start some kind of promotional campaign. Open the flood gates! The acne market is a $3 Billion market and with a superior product, Wasatch will aggressively penetrate and control a significant share of this market. If they owned just 10% of this market, which is easily acheivable with the right medicine and the right advertising, they could be a highly profitable and on the move company. They might be using that $25 million to advertise.... WASP is now receiving long term funding and will receive up to $25 million over the next twelve months. This funding will be accomplished through a private placement with institutional buyers who will be long term holders of Wasatch Pharmaceutical Inc. stock. If this really is "institutional" investors, this could be a really good thing. I would be interested to know what their cost basis is and if their shares are restricted. But, none the less, to drop $25 million, somebody knows this is going to be huge. Cystic Acne Study Brings Dramatic Results Wasatch has announced a success rate of 95% with virtually no side effects. Success is interpreted as total or near Company has other drugs in the pipeline, to do with eczema, acne and psoriasis. Very impressive. Didn't Viagra have a success rate near 95%? I think that did well for Pfizer stock LOL Also interesting, that ACNE is not their ownly products..Have developments in eczema, and psoriasis. Acne will be the first out of the stables. Because the Company is now receiving major funding, there will be announcements over the next few weeks concerning activities within Wasatch This is almost like a warning to the investors that its going to heat up reallllyyy soon. Will probably hit day traders screens when they release this news. So, it will be volatile. Interesting though! Issued and outstanding approximately 15 million. On the float approximately 3.5 million. Nice share count. Nice float. Just need to see about the PP Just my opinions! FM